Syndromic agammaglobulinemia
MONDO:0016463A agammaglobulinemia that is part of a larger syndrome.
Also known as: hypogammaglobulinemia, syndrome associated with agammaglobulinemia, syndromic agammaglobulinemia, syndromic hypogammaglobulinemia
74 clinical trials for this condition and its sub-types, 7 tagged with Syndromic agammaglobulinemia itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Syndromic agammaglobulinemia
-
Common variable immunodeficiency 29 trials · 31 incl. sub-types
16 sub-types
- Immunodeficiency, common variable, 12 1 trial
- Pancytopenia due to IKZF1 mutations 1 trial
- IL21-related infantile inflammatory bowel disease 0 trials
- Combined immunodeficiency due to LRBA deficiency 0 trials
- Immune deficiency, familial variable 0 trials
- Immunodeficiency, common variable, 1 0 trials
- Immunodeficiency, common variable, 10 0 trials Sub-types →
- Immunodeficiency, common variable, 14 0 trials
- Immunodeficiency, common variable, 15 0 trials
- Immunodeficiency, common variable, 2 0 trials
- Immunodeficiency, common variable, 3 0 trials
- Immunodeficiency, common variable, 4 0 trials
- Immunodeficiency, common variable, 5 0 trials
- Immunodeficiency, common variable, 6 0 trials
- Immunodeficiency, common variable, 7 0 trials
- Immunodeficiency, common variable, due to APRIL deficiency 0 trials
-
Transient hypogammaglobulinemia 0 trials
1 sub-type
Most studied deeper sub-types
-
Rare disease drug shows promise in reducing infections
Disease control CompletedThis study tested two drugs, plerixafor and G-CSF, in 20 people with WHIM syndrome, a rare genetic condition that causes frequent infections and warts. Participants received each drug for a year and tracked their infections. The goal was to see which drug better reduced infection…
Phase 2/3 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Can antibody infusions shield CLL patients from deadly infections?
Disease control CompletedThis study tested whether regular infusions of Panzyga (a concentrated antibody solution from donated blood) could prevent serious infections in people with chronic lymphocytic leukemia (CLL) who also have low antibody levels. The trial included 247 adults with CLL who were recei…
Phase 3 • Sponsor: Octapharma • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC